Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma
Clinical trial NCT04853329 · TERMINATED
Trial details
- NCT number
- NCT04853329
- Sponsor
- Conjupro Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2023-01-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.